A Single Center, Open-Label Study Evaluating the Ability of 99mTc-Tilmanocept to Identify Clipped Nodes in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy and Sentinel Lymph Node Assessment

Activity: Other

Description

Cardinal Health
$100,000 Role: PI;
Goal: Study the accuracy of Lymphossek in identifying the clipped node in the neoadjuvant setting
Period2021 → 2023